Last reviewed · How we verify
NCT03910153
Effect of MSPrebiotic on Gastrointestinal Function and Blood Glucose Levels
NA trial testing MSPrebiotic in Gastrointestinal Function in 110 participants. Completed in 7 October 2019.
7 October 2019
Quick facts
| Lead sponsor | MSP Starch Products Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 8 April 2019 |
| Primary completion | 7 October 2019 |
| Estimated completion | 7 October 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- MSPrebiotic
- Placebo
Conditions studied
- Gastrointestinal Function — all drugs for Gastrointestinal Function →
Sponsor
MSP Starch Products Inc.
Who can join
30 and older, any sex, with Gastrointestinal Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to investigate the impact of daily consumption of MSPrebiotic at a dosage level of 30 g per day for 12 weeks on gastrointestinal microbiota in the elderly (\> 70 years age) and another age group (30 to 50 years). In addition, impact of MSPrebiotic on short chain fatty acids, glucose and insulin levels as well as metabolomic changes will also be studied. A randomized, double-blinded study will be conducted to assess the health benefits of MSPrebiotic and compared with a placebo. This study will provide substantiation for a beneficial effect of MSPrebiotic resistant starch on gut microbiome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03910153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrointestinal Function
Currently open trials in the same condition.
- NCT07081100 — Probiotics and Non-Organic Gastrointestinal Improvement · NA · recruiting
- NCT07388264 — Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes · NA · recruiting
- NCT07208955 — The Effect of Heat Application and Abdominal Massage on the Gastrointestinal System and Mental Well-being of Patients Wi · NA · active not recruiting
- NCT06368713 — Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients · NA · recruiting
Other MSP Starch Products Inc. trials
Trials by the same sponsor.
- NCT06949631 — Study on the Effects of Resistant Potato Starch on Gut Bacteria in Healthy Adults · NA · completed
- NCT05242913 — Effects of Resistant Potato Starch on the Gut Microbiota · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03910153 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MSP Starch Products Inc.
- Last refreshed: 25 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03910153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing